Dexmethylphenidate HCl extended-release capsules
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
ADHD, ADD
Conditions
ADHD, ADD
Trial Timeline
Feb 1, 2006 → Nov 1, 2006
NCT ID
NCT00301236About Dexmethylphenidate HCl extended-release capsules
Dexmethylphenidate HCl extended-release capsules is a phase 3 stage product being developed by Novartis for ADHD, ADD. The current trial status is completed. This product is registered under clinical trial identifier NCT00301236. Target conditions include ADHD, ADD.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00301236 | Phase 3 | Completed |
Competing Products
20 competing products in ADHD, ADD